Benzinga | Nov 9, 2020 07:41AM EST

Sesen Bio Q3 EPS $(0.19) Misses $(0.08) Estimate, Sales $11.20M

Sesen Bio (NASDAQ:SESN) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.08) by 137.5 percent. This is a 46.15 percent decrease over losses of $(0.13) per share from the same period last year. The company reported $11.20 million in sales this quarter.